David has been instrumental in shaping the identify and success of Slade Health and Slade Pharmacy. His father, Graham Slade, founded Slade Pharmacy in 1965, establishing the values of integrity, innovation and customer care that continue to guide our pharmacies today.
Since joining the business in 1997, David has led its transformation into a market leader in pharmacy services for the private hospital and oncology sectors. In 2012, he founded Slade Health, which has since grown to become one of Australia’s largest chemotherapy compounding providers with four TGA licensed compounding facilities in Australia and has now expanded internationally to New Zealand.
David’s leadership was instrumental in Slade’s growth across pharmacy and compounding which has seen further expansion of high-quality hospital pharmacy and oncology services. His proven industry reputation was also critical in Icon Group’s acquisition of the United Kingdom’s Pharmaxo Group, a leading pharmaceutical specialist compounder and clinical pharmacy homecare provider.
From pioneering robotic dispensing and online chemotherapy ordering to establishing Australia’s first paperless compounding service and in-house stability testing laboratory, his vision has enhanced patient safety, efficiency and access to medicines.
David remains a key part of Slade Health and continues to consult and champion the values passed down by his father while leaving a lasting legacy of growth, innovation, customer service and global impact.